11月6款创新药有望获FDA批准

动脉网
Nov 02, 2025

2024年美国FDA批准超60款创新疗法和疫苗,药明康德将持续助力全球病患获得突破性疗法。预计2025年11月,FDA将对6款创新药物批准做监管决定。其中,Biohaven公司的Troriluzole,用于治疗脊髓小脑共济失调症(SCA),其主要作用机制是减少突触中的谷氨酸水平,今年2月FDA受理其新药申请并授予优先审评资格,若获批将成为首个治疗SCA的FDA批准药物,BHV4157-206-...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10